U.S. market Closed. Opens in 5 hours 4 minutes

ERYP | ERYTECH Pharma S.A. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
RevenueN/AN/AN/A3.36M4.14MN/AN/AN/AN/A1.80MN/A
Cost of RevenueN/AN/A57.58M52.19M33.47M25.46M19.72M10.78M6.61M5.33M3.46M
Gross ProfitN/AN/A-57.58M-48.83M-29.33M-25.46MN/AN/AN/A-3.53MN/A
Operating Expenses27.15M56.52M68.83M64.07M10.15M5.42M2.67M4.81M2.34M1.76M-2.39M
Selling, General & Admin13.89M15.10M14.97M17.16M14.60M8.52M6.66M7.62M4.36M3.55M3.30M
Research & Development19.91M45.10M57.58M52.19M-19.72MN/AN/AN/AN/A2.50MN/A
Other Operating Expenses-6.65M-3.69M-3.72M-5.28M-4.45M-3.10M-3.99M-2.81M-2.03M-4.29M-5.68M
Operating Income-2.80M-56.52M-68.83M-64.07M-43.62M-30.89M-22.39M-15.58M-8.95M-7.09M-1.07M
Other Expenses / Income3.09M2.72M-4.46M1.41M5.40M-2.64M488.00K568.00K68.17K-1.10M-1.09M
Before Tax Income293.00K-53.80M-73.30M-62.66M-38.22M-33.53M-21.90M-15.02M-8.88M-8.18M-2.16M
Income Tax Expenses521.00K2.00K3.00K-1.00K2.00K-3.00K10.00K-3.00K-20.16K-40.02K7.64K
Net Income-228.00K-53.80M-73.30M-62.66M-38.22M-33.53M-21.91M-15.01M-8.86M-8.14M-2.17M
Interest Expenses1.36M2.14M5.35M1.53M9.00K15.00K4.00K5.00K6.80K4.66K9.38K
Basic Shares Outstanding31.02M23.69M18.39M17.94M17.94M17.94M7.98M6.96M5.87M4.69M5.54M
Diluted Shares Outstanding31.02M23.69M18.39M17.94M17.94M17.94M7.98M6.96M5.87M4.69M5.54M
EBITDA-22.69M-47.45M-67.94M-61.13M-37.42M-32.99M-21.47M-15.25M-8.74M-8.00M-1.87M
EBITDA Margin0.00%0.00%0.00%-1,817.09%-904.20%0.00%0.00%0.00%0.00%-443.87%0.00%
EBIT1.66M-51.66M-67.94M-61.13M-38.21M-33.52M-21.90M-15.01M-8.87M-8.18M-2.16M
EBIT Margin0.00%0.00%0.00%-1,817.09%-923.47%0.00%0.00%0.00%0.00%-453.88%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙